Page 70 - 2_DIATMHMATIKO_PROGRAMMA

RezumTM
Water Vapour Therapy
Sustained clinical outcomes through 5 years1
Final study results demonstrate RezūmTM Water Vapour Therapy is a safe and efficient BPH treatment that effectively relieves symptoms and preserves sexual function out to 5 years.
Surgical retreatment rate after RezūmTM therapy
31%
of men in study treated for MLO
Long-term Durability
Compared to baseline
International Prostate Peak Urinary Quality of Life Symptom Score Flow Rate Improvementt
Versatile to Treat Median Lobe Obstruction (MLO)
Rezūm can treat lateral and central zones without physicians having to learn an advanced technique
Positive Safety Profile and Preserves Sexual Function
No late occurring adverse events or de novo erectile dysfunction reported at 5 years
BPH Impact Index
For more information about the clinical trial or RezūmTM Water Vapour Therapy,
visit www.bostonscientific.com/Rezum/Sustained-Durability
Potential risks associated with Rezūm Water Vapour Therapy include but are not limited to dysuria, hematuria, hematospermia, decrease in ejaculatory volume, suspected urinary tract infection (UTI), urinary frequency, and retention or urgency.
1. McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of Rezūm water vapor thermal therapy for treatment of moderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 19. April 2021.
2. McVary KT, Roehrborn C. Five year results of the prospective, randomized, controlled trial of water thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. J Urol. 2020;203: e1021.
URO
70
www.bostonscientific.eu
/P
4.4 %
after 5 years2
H-821401-AB © 2021 Boston Scientific Corporation or its affiliates. All rights reserved. DINURO2491EA
48%
IPSS
44%
Qmax
45%
IPSS-QOL
48%
BPHII